Literature DB >> 6829676

A clinicopathologic study of optic neuropathies associated with intracranial mass lesions with quantification of remaining axons.

P S Levin, S A Newman, H A Quigley, N R Miller.   

Abstract

We examined three patients with intracranial mass lesions that damaged the anterior visual pathway and studied this damage histologically after the patients died. Estimation of the number of surviving axons in the six optic nerves generally showed the greatest atrophy to be in the temporal sector in cross sections immediately behind the globe. More posterior to the globe, atrophy appeared greatest in the center of several nerves. This pattern of damage may result from particular vulnerability of macular axons to damage along the anterior visual pathway. Optic disk pallor was present in two eyes that had less than 40% of the normal number of axons remaining, while one optic disk appeared to be normal with 70% of the axons intact. Afferent pupillary defects were observed in two patients who had two to three times as many remaining axons in the contralateral optic nerve as in the nerve on the side of the defect.

Entities:  

Mesh:

Year:  1983        PMID: 6829676     DOI: 10.1016/s0002-9394(14)78297-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Microtissue engineered constructs with living axons for targeted nervous system reconstruction.

Authors:  D Kacy Cullen; Min D Tang-Schomer; Laura A Struzyna; Ankur R Patel; Victoria E Johnson; John A Wolf; Douglas H Smith
Journal:  Tissue Eng Part A       Date:  2012-08-17       Impact factor: 3.845

2.  Rebuilding Brain Circuitry with Living Micro-Tissue Engineered Neural Networks.

Authors:  Laura A Struzyna; John A Wolf; Constance J Mietus; Dayo O Adewole; H Isaac Chen; Douglas H Smith; D Kacy Cullen
Journal:  Tissue Eng Part A       Date:  2015-10-23       Impact factor: 3.845

3.  Quantification of retinal nerve fiber layer thickness reduction associated with a relative afferent pupillary defect.

Authors:  Yoriko Nakanishi; Makoto Nakamura; Yasuko Tatsumi; Azusa Nagai-Kusuhara; Akira Negi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-21       Impact factor: 3.117

4.  Visual acuity in optic atrophy: a quantitative clinicopathological analysis.

Authors:  L Frisén; H A Quigley
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1984       Impact factor: 3.117

Review 5.  Invasiveness of primary brain tumors.

Authors:  O D Laerum; R Bjerkvig; S K Steinsvåg; L de Ridder
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  Optic nerve trauma: clinical, electrophysiological and histological remarks.

Authors:  H E Nau; L Gerhard; M Foerster; H C Nahser; V Reinhardt; T Joka
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

Review 7.  Biomaterial and tissue-engineering strategies for the treatment of brain neurodegeneration.

Authors:  Bridget Martinez; Philip V Peplow
Journal:  Neural Regen Res       Date:  2022-10       Impact factor: 6.058

8.  More sensitive correlation of afferent pupillary defect with ganglion cell complex.

Authors:  Eulogio Besada; Barry J Frauens; Rim Makhlouf; Diana Shechtman; Julie Rodman; Marlon Demeritt; Patrick Hardigan
Journal:  J Optom       Date:  2017-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.